Menopause and Hair Loss — What's Actually Happening, and What Helps

The short answer: it's not that androgens rise, it's that estrogen falls faster

The common explanation you'll see for menopausal hair loss is "androgens take over" — implying testosterone spikes once estrogen drops. That's not quite accurate, and the real mechanism is more interesting. Androgen levels (testosterone, DHEA-S) generally don't rise in absolute terms during menopause. What actually happens is that estrogen and progesterone fall much faster than androgens do, creating what researchers call relative androgen dominance — the counterbalancing hormones that normally keep androgen effects in check simply aren't there anymore in the same proportion.

There's a second, compounding factor: SHBG (sex hormone-binding globulin) — a protein that binds testosterone and keeps it biologically inactive — tends to fall during menopause too. Less SHBG means more "free," biologically active testosterone circulating even if total testosterone hasn't changed. That free testosterone converts to DHT (dihydrotestosterone) via an enzyme called 5-alpha reductase, and in women genetically predisposed to androgenetic alopecia, DHT binds to hair follicle receptors and triggers progressive miniaturization — each growth cycle producing a thinner, shorter strand than the last.

How common is this, really?

This isn't a fringe concern — female pattern hair loss (the technical term is androgenetic alopecia, or FPHL) is the most common form of hair loss in women overall, with prevalence rising significantly after menopause. If you're noticing thinning in your 40s and were told it's "just stress" or "just aging," the hormonal mechanism above is very likely playing a real role, and it's worth naming specifically with a provider rather than accepting a vague explanation.

What's actually changing in your hair, not just your hormones

Estrogen and progesterone help keep hair follicles in the anagen (active growth) phase of the hair cycle for longer. As these hormones fall, more follicles shift into the telogen (resting and shedding) phase at any given time — some research describes this as the hair follicle itself "going through menopause" alongside the rest of the body. Practically, this shows up as:

• Decreased density — more visible scalp, especially at the crown and part line
• Decreased hair shaft caliber — individual strands become thinner, not just fewer in number
• Changes in texture — hair that was straight may become wavier or more brittle, and vice versa
• Slower regrowth — reduced blood flow and metabolic support to the follicle unit means replacement hair grows back more slowly after normal shedding

The GLP-1 connection — why this matters if you're also losing weight

If you're a perimenopausal or menopausal woman considering a GLP-1 medication for weight loss, this is worth understanding before you start: GLP-1 medications are a well-documented trigger for telogen effluvium, the temporary, diffuse shedding type described above — driven by the physical stress of rapid weight loss on the body, not by hormones or genetics specifically. It typically starts 2-4 months after beginning treatment or a significant weight-loss phase, and resolves within 6-12 months as the body adjusts.

Here's the compounding scenario worth planning for: a menopausal woman already experiencing gradual, hormone-driven androgenetic thinning who then starts a GLP-1 and loses weight quickly can experience both hair loss mechanisms at once — the slow, progressive hormonal pattern plus a temporary stress-shedding episode layered on top. The total shedding can feel much more dramatic than either cause alone, which understandably alarms people, but understanding that it's two different, separately explainable mechanisms — one temporary, one hormonal — helps set realistic expectations rather than assuming something has gone seriously wrong.

What actually works — graded honestly by evidence strength

The most genuinely new development here is clascoterone — a topical androgen receptor inhibitor that showed up to a 539% relative improvement in hair count versus placebo in December 2025 Phase 3 results, with FDA submission expected sometime in 2026. If approved, it would be the first new hair loss treatment mechanism in roughly three decades. It is not available yet, and no legitimate source can sell it to you before FDA approval — worth knowing so you're not misled by anyone claiming early access.

The right hormone workup — what to actually ask for

If you want to understand what's driving your specific hair loss rather than guessing, the relevant panel includes:

• Total and free testosterone — free testosterone is the more clinically relevant number, since it reflects what's actually available to bind follicle receptors
• DHEA-S — an adrenal-derived androgen precursor worth checking alongside testosterone
• SHBG — low SHBG raises the free androgen index even when total testosterone looks normal, and is frequently the missing piece in a standard workup
• Estradiol and FSH — confirms perimenopausal or menopausal status and provides context for the rest of the panel

This is the same panel logic behind our full guide to testosterone therapy for women in menopause — hair loss is frequently one symptom in a broader pattern that includes fatigue, low libido, and difficulty maintaining muscle, all traceable to the same underlying hormonal shifts.

When to see a specialist instead of managing this yourself

• See a dermatologist if hair loss shows a scarring pattern, occurs in distinct patches rather than diffuse thinning, or doesn't meaningfully respond to first-line treatment like minoxidil after about 6 months
• See an endocrinologist if hair loss comes with signs of rapid virilization — a notably deepening voice, significant new facial hair, or clitoral enlargement — which suggests something outside the normal range of relative androgen dominance and warrants real investigation

Our take

Menopausal hair loss is real, common, and driven by a genuinely understandable hormonal mechanism — not a mystery, and not something to just accept as an unfixable part of aging. The evidence-backed options today (minoxidil, and off-label finasteride for the right candidates) are real but modest; the more exciting development (clascoterone) isn't available yet. If you're also considering a GLP-1 for weight loss during this same window, understanding that you might be layering two different hair-loss mechanisms — one temporary, one hormonal — helps you interpret what you're seeing accurately instead of panicking or assuming the worst.

Frequently asked questions